| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Application of genetically engineered Salmonella typhimurium for interferon-gamma–induced therapy against melanoma
|
Yoon, Wonsuck
|
|
2017
|
70 |
C |
p. 48-61
14 p.
|
artikel
|
| 2 |
Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation
|
Miles, David
|
|
2017
|
70 |
C |
p. 146-155
10 p.
|
artikel
|
| 3 |
Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: A population-based cohort study
|
Luo, Jing
|
|
2017
|
70 |
C |
p. 22-33
12 p.
|
artikel
|
| 4 |
Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer
|
Yap, Timothy A.
|
|
2017
|
70 |
C |
p. 12-21
10 p.
|
artikel
|
| 5 |
Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014
|
Carlander, Amanda-Louise Fenger
|
|
2017
|
70 |
C |
p. 75-82
8 p.
|
artikel
|
| 6 |
Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28]
|
Tsimafeyeu, Ilya
|
|
2017
|
70 |
C |
p. 156-
1 p.
|
artikel
|
| 7 |
Current therapy and the evolving molecular landscape of paediatric ependymoma
|
Khatua, Soumen
|
|
2017
|
70 |
C |
p. 34-41
8 p.
|
artikel
|
| 8 |
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial
|
Rouzier, Roman
|
|
2017
|
70 |
C |
p. 133-142
10 p.
|
artikel
|
| 9 |
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer
|
Marth, Christian
|
|
2017
|
70 |
C |
p. 111-121
11 p.
|
artikel
|
| 10 |
European Journal of Cancer’s Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas
|
Blay, Jean-Yves
|
|
2017
|
70 |
C |
p. 83-86
4 p.
|
artikel
|
| 11 |
Healthy dietary patterns and incidence of biliary tract and gallbladder cancer in a prospective study of women and men
|
Larsson, Susanna C.
|
|
2017
|
70 |
C |
p. 42-47
6 p.
|
artikel
|
| 12 |
Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
|
Skotland, Tore
|
|
2017
|
70 |
C |
p. 122-132
11 p.
|
artikel
|
| 13 |
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair
|
Saponara, Maristella
|
|
2017
|
70 |
C |
p. 1-11
11 p.
|
artikel
|
| 14 |
Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles
|
Read, Jolene
|
|
2017
|
70 |
C |
p. 62-74
13 p.
|
artikel
|
| 15 |
Plasma vascular endothelial growth factor as a predictive biomarker: Door closed?
|
Rana, Punam
|
|
2017
|
70 |
C |
p. 143-145
3 p.
|
artikel
|
| 16 |
Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis
|
Höckel, Michael
|
|
2017
|
70 |
C |
p. 99-110
12 p.
|
artikel
|
| 17 |
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
|
Holch, Julian Walter
|
|
2017
|
70 |
C |
p. 87-98
12 p.
|
artikel
|
Tijdschrift beschrijving